BridgeBio Pharma
The Medical Operations Manager, EU West, reports to the Medical Director and partners with the Medical Advisor to build the operating backbone for three rare-disease launches in France. This role owns the planning, logistics, systems, and financial coordination of Medical Affairs activities while coordinating local regulatory, compliance, and LEA workflows to ensure efficient and auditable execution. The position focuses on France with regular travel across the country and periodic travel to Switzerland and other Europe West locations.
Headquarters
Palo Alto, California, United States
Company Size
201-500 employees
Founded
2014
BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers driven by clear genetic causes. The company advances programs from target discovery through clinical development, combining human genetics and translational science with rigorous clinical trials to create targeted therapeutics. BridgeBio builds a diversified portfolio of wholly owned and partnered programs across multiple modalities and uses a venture‑style operating model to accelerate and de‑risk development. Its mission is to translate genetic insights into precision medicines for patients with high unmet medical need.
A Look At BridgeBio Pharma (BBIO) Valuation After Recent Share Price Volatility
6 hours ago
BridgeBio Builds Case for Early 2027 Launch of Dystrophy Drug
7 hours ago
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BridgeBio Pharma.
BridgeBio Pharma didn’t post a salary, so this is our estimate from similar listings.
32% below the average for this role
Why Is BridgeBio Pharma Stock Soaring Tuesday? - BridgeBio Pharma (NASDAQ:BBIO)
2 days ago
Vice President, Head of US Medical Affairs, Rare Disease
Ipsen
Hematology Medical Director, VEXAS
Sobi
Head of Medical Affairs, France
Genmab
Pediatric Rare Disease Medical Science Liaison - West Territory
Ipsen
Medical Science Liaison – South Central Region
Beam Therapeutics
Senior Medical Science Liaison (MSL), Rare Disease - West
Acadia Pharmaceuticals Inc.